Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

These medications for BPH have known risks and may have new side effects.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride may reduce prostate cancer risk.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Older patients sticking to their prostate medication saw lasting health benefits.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Finasteride effectively reduces the need for surgery and urinary issues in men with BPH over the long term.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Finasteride effectively treats BPH by reducing prostate size and improving symptoms.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Taking dutasteride every other day works as well as daily and better preserves sexual function.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Rats had lasting erectile problems after stopping a certain medication.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

The normal human prostate does not significantly affect blood DHT levels.